Anixa Biosciences, Inc.
Anixa Biosciences, Inc. logo
ANIX

Anixa Biosciences, Inc. (ANIX)

$5.044.78%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.64
Day's Range
$5.04
$2.3
52-Week Range
$6.25
1 month return10.8%
3 month return17.21%
1 year return46.51%
5 year return105.71%

Company Information

Anixa Biosciences Inc. is a biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function. The company's vaccine portfolio includes a vaccine to prevent breast cancer, and specifically triple negative breast cancer (TNBC), the most deadly form of the disease, and a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against specific proteins that have been found to be expressed in certain forms of cancer. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.
OrganizationAnixa Biosciences, Inc.
Employees4
CEODr. Amit Kumar Ph.D.
IndustryElectronic Technology

Analyst Recommendation

based on 1 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 1 Wall street analysts offering stock ratings for Anixa Biosciences, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 118.25%

Current

$5.04

Target

$11.0

Recommendation Trend

Based on 1 analyst

Current1M Ago3M Ago
Buy
1
6
6
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
147.5M
Book Value
$1.03
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.52
Wall Street Target Price
11.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
4.78
Enterprise Value
120.0M
Enterprise Value/Revenue
91.01
Enterprise Value/Ebitda
-8.4

Technicals

Beta
1.14
50 Day MA
5.1
200 Day MA
3.77

Institutional Holdings

Vanguard Group Inc

4.24%

UBS Group AG

1.97%

Geode Capital Management, LLC

0.88%

Long Focus Capital Management, LLC

0.54%

State Street Corporation

0.33%

Bank of New York Mellon Corp

0.32%

Discover more

Frequently Asked Questions

What is Anixa Biosciences, Inc. share price today?

Can Indians buy Anixa Biosciences, Inc. shares?

How can I buy Anixa Biosciences, Inc. shares from India?

Can Fractional shares of Anixa Biosciences, Inc. be purchased?

What are the documents required to start investing in Anixa Biosciences, Inc. stocks?

What are today’s High and Low prices of Anixa Biosciences, Inc.?

What are today’s traded volumes of Anixa Biosciences, Inc.?

What is today’s market capitalisation of Anixa Biosciences, Inc.?

What is the 52 Week High and Low Range of Anixa Biosciences, Inc.?

How much percentage Anixa Biosciences, Inc. is down from its 52 Week High?

How much percentage Anixa Biosciences, Inc. is up from its 52 Week low?

What are the historical returns of Anixa Biosciences, Inc.?

Who is the Chief Executive Officer (CEO) of Anixa Biosciences, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*